Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2010 2
2011 3
2012 1
2013 3
2014 1
2015 2
2016 2
2017 7
2018 2
2019 6
2020 8
2021 4
2022 8
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Methods-Motivational Interviewing Approach for Enhanced Retention and Attendance.
Jake-Schoffman DE, Brown SD, Baiocchi M, Bibeau JL, Daubenmier J, Ferrara A, Galarce MN, Hartogensis W, Hecht FM, Hedderson MM, Moran PJ, Pagoto SL, Tsai AL, Waring ME, Kiernan M. Jake-Schoffman DE, et al. Among authors: hartogensis w. Am J Prev Med. 2021 Oct;61(4):606-617. doi: 10.1016/j.amepre.2021.04.005. Am J Prev Med. 2021. PMID: 34544560 Free PMC article.
Protocol for a randomized controlled trial comparing a very low-carbohydrate diet or moderate-carbohydrate plate-method diet for type 2 diabetes: the LEGEND (Lifestyle Education about Nutrition for Diabetes) trial.
Saslow LR, Eslamian A, Moran P, Hartogensis W, Mason AE, Kim S, Bauer DC, Griauzde DH, Goldman V, Liu V, Stephens P, Raymond K, Yeung G, Leung C, Hecht FM. Saslow LR, et al. Among authors: hartogensis w. Trials. 2023 Jul 20;24(1):463. doi: 10.1186/s13063-023-07512-9. Trials. 2023. PMID: 37475033 Free PMC article.
Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria.
Fajnzylber J, Sharaf R, Hutchinson JN, Aga E, Bosch RJ, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest DJ, Margolis D, Sneller MC, Little SJ, Gulick RM, Mellors JW, Gandhi RT, Schooley RT, Henry K, Tebas P, Deeks S, Chun TW, Collier AC, Hecht FM, Li JZ; CHAMP study team. Fajnzylber J, et al. Among authors: hartogensis w. AIDS. 2021 Nov 1;35(13):2225-2227. doi: 10.1097/QAD.0000000000002978. AIDS. 2021. PMID: 34127579 Free PMC article.
Detection of COVID-19 using multimodal data from a wearable device: results from the first TemPredict Study.
Mason AE, Hecht FM, Davis SK, Natale JL, Hartogensis W, Damaso N, Claypool KT, Dilchert S, Dasgupta S, Purawat S, Viswanath VK, Klein A, Chowdhary A, Fisher SM, Anglo C, Puldon KY, Veasna D, Prather JG, Pandya LS, Fox LM, Busch M, Giordano C, Mercado BK, Song J, Jaimes R, Baum BS, Telfer BA, Philipson CW, Collins PP, Rao AA, Wang EJ, Bandi RH, Choe BJ, Epel ES, Epstein SK, Krasnoff JB, Lee MB, Lee SW, Lopez GM, Mehta A, Melville LD, Moon TS, Mujica-Parodi LR, Noel KM, Orosco MA, Rideout JM, Robishaw JD, Rodriguez RM, Shah KH, Siegal JH, Gupta A, Altintas I, Smarr BL. Mason AE, et al. Among authors: hartogensis w. Sci Rep. 2022 Mar 2;12(1):3463. doi: 10.1038/s41598-022-07314-0. Sci Rep. 2022. PMID: 35236896 Free PMC article.
Psoriasis risk SNPs and their association with HIV-1 control.
Nititham J, Gupta R, Zeng X, Hartogensis W, Nixon DF, Deeks SG, Hecht FM, Liao W. Nititham J, et al. Among authors: hartogensis w. Hum Immunol. 2017 Feb;78(2):179-184. doi: 10.1016/j.humimm.2016.10.018. Epub 2016 Oct 31. Hum Immunol. 2017. PMID: 27810495 Free PMC article.
Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral Therapy.
Stern J, Solomon A, Dantanarayana A, Pascoe R, Reynaldi A, Davenport MP, Milush J, Deeks SG, Hartogensis W, Hecht FM, Cockerham L, Roche M, Lewin SR. Stern J, et al. Among authors: hartogensis w. J Infect Dis. 2022 May 16;225(10):1721-1730. doi: 10.1093/infdis/jiab533. J Infect Dis. 2022. PMID: 34655216 Free PMC article.
Metrics from Wearable Devices as Candidate Predictors of Antibody Response Following Vaccination against COVID-19: Data from the Second TemPredict Study.
Mason AE, Kasl P, Hartogensis W, Natale JL, Dilchert S, Dasgupta S, Purawat S, Chowdhary A, Anglo C, Veasna D, Pandya LS, Fox LM, Puldon KY, Prather JG, Gupta A, Altintas I, Smarr BL, Hecht FM. Mason AE, et al. Among authors: hartogensis w. Vaccines (Basel). 2022 Feb 9;10(2):264. doi: 10.3390/vaccines10020264. Vaccines (Basel). 2022. PMID: 35214723 Free PMC article.
58 results